IFP Advisors
WVE icon

IFP Advisors’s Wave Life Sciences WVE Stock Holding History

IFP Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.66K Sell
749
-1,412
-65% -$7.43K ﹤0.01% 3958
2026
Q2 		$12.6K Buy
2,161
+2,152
+23,911% +$14.3K ﹤0.01% 3251
2026
Q1 		$65 Hold
9
– – ﹤0.01% 4800
2025
Q4 		$153 Buy
+9
New +$91 ﹤0.01% 4520
2025
Q2 		– Hold
0
– – – 3283
2025
Q1 		– Hold
0
– – – 3969
2024
Q4 		– Hold
0
– – – 3958
2020
Q4 		– Sell
-38
Closed -$319 – 3118
2020
Q3 		$0 Buy
+38
New +$417 ﹤0.01% 3022

Other funds holding WVE

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

IFP Advisors's WVE Position: Q3 2026 in Review

IFP Advisors reduced its Wave Life Sciences (WVE) stake by 65% in Q3 2026, selling an estimated $7.43K and leaving 749 shares worth $3.66K. The position accounts for ﹤0.01% of the portfolio, ranked #3958.

IFP Advisors first reported a position in WVE in Q3 2020 and has held it in 5 quarters since. The position peaked at $12.6K in Q2 2026. 67 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • IFP Advisors held 749 shares of Wave Life Sciences worth $3.66K as of Q3 2026.
  • IFP Advisors sold 1,412 Wave Life Sciences shares in Q3 2026, an estimated $7.43K.
  • Wave Life Sciences made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3958 holding.
  • IFP Advisors first reported a position in Wave Life Sciences in Q3 2020 and has held it in 5 quarters since.
  • IFP Advisors's Wave Life Sciences position peaked at $12.6K in Q2 2026.
  • 67 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.